TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard

➔ TerrAscend
CSE Ticker: TER
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 249 as of 5/15/19
Established: 2014
CEO: Dr. Michael Nashat

TerrAscend – Cannabis Facilities


  • 67,300 sq. ft wholly owned facility strategically located in Mississauga, Ontario
  • Hydroponic cultivation facility licensed under the ACMPR
  • Current licensed space includes:
    • Two flower rooms
    • Vegetation room
    • Trimming/drying room
    • Packaging room
    • Order fulfillment room
    • Level 10 vault
    • Deconstruction room
    • Additional supporting areas
  • Proposed 6,500-square-foot Drug Preparation Premises for compounding of sterile and non-sterile formulations under the Pharmacy Act, 1991
  • Expansion to include 22,000 square feet of cultivation and support space with 10,000 square feet available for cultivation
  • GMP certified
  • Expansion to result in 1,200 to 1,500 kilograms of annual cultivation capacity


  • 16-acre site in New Jersey
  • Up to 80,000 square feet of cultivation and 40,000 square feet of processing
  • New Jersey retail to be located in Philipsburg with sales expected to begin in Q4 2019

Visit TerrAscend, Inc.
at www.terrascend.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.